EP2654730A2 — High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
Assigned to KRKA dd · Expires 2013-10-30 · 13y expired
What this patent protects
The subject of the invention includes a high drug load pharmaceutical composition comprising dronedarone or its pharmaceutically acceptable salts, in particular dronedarone HCI as the active pharmaceutical ingredient, comprising micronized particles of the active ingredient and o…
USPTO Abstract
The subject of the invention includes a high drug load pharmaceutical composition comprising dronedarone or its pharmaceutically acceptable salts, in particular dronedarone HCI as the active pharmaceutical ingredient, comprising micronized particles of the active ingredient and optionally ionic surfactants.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.